Fulltext

Monitoring medicines use to support national medicines policy development and implementation in the Asia Pacific region

Roughead EE 1 , Lhazeen K 2 , Socialine E 3 , Bahri S 4 , Park BJ 5 , Holloway K 6

Affiliations 

  • 1 Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia
  • 2 Department of Medical Services, Chief Programme Officer in Essential Medicine and Technology Division, Ministry of Health, Bhutan
  • 3 Directorate General of Pharmaceutical Services and Medical Devices, Ministry of Health, Indonesia
  • 4 Director of Pharmacy Practice and Development, Ministry of Health, Malaysia
  • 5 Department of Preventative Medicine, Seoul National University College of Medicine, Seoul, Korea and Korea Institute of Drug Safety and Risk Management, Seoul, Republic of Korea; Regional Adviser in Essential Medicines, World Health Organization Regional Office for South-East Asia, New Delhi, India
  • 6 Regional Adviser in Essential Medicines, World Health Organization Regional Office for South-East Asia, New Delhi, India
WHO South East Asia J Public Health, 2013 Apr-Jun;2(2):113-117.
PMID: 28612769 DOI: 10.4103/2224-3151.122946

Abstract

Critical to the successful implementation of a national medicines strategy is evaluation of the policy and ongoing monitoring of medicine use. Methods for monitoring medicines use within countries vary depending on the country and its stage of medicines policy development and implementation. In this paper, we provide four case studies on monitoring medicines use to support national medicines policy development and implementation. Cases come from Bhutan, Indonesia, Malaysia and the Republic of Korea.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications